Atreca, Inc.

United States of America


Create a watch for Atreca, Inc.
Total IP 55
Total IP Rank # 25,501
IP Activity Score 2.5/5.0    35
IP Activity Rank # 21,529
Stock Symbol
ISIN US04965G1094
Market Cap. 506M  (USD)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Scientific, technological and in...

Patents

Trademarks

16 6
1 4
22 2
4
 
Last Patent 2025 - Anti-csp antibody variants
First Patent 2012 - Dna barcodes for multiplexed seq...
Last Trademark 2021 - ATRECA
First Trademark 2011 - ATRECA

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 Invention Anti-csp antibody variants. The present disclosure provides anti-circumsporozoite (CSP) antibodie...
2023 Invention Antibody scaffold structure. Provided herein are antibodies comprising a scaffold region and met...
Invention Epha2 antibodies. Provided herein immunoconjugate comprising an antibody that binds to ephrin rec...
Invention Anti-tumor antibodies. Provided herein are antibodies that target tumors, wherein the binding of ...
Invention Anti-csp antibodies. The present disclosure provides anti-circumsporozoite (CSP) antibodies, com...
2022 Invention Antibodies to coronavirus sars-cov-2. Described herein are antibodies or variants thereof that s...
Invention Antibodies to coronavirus sars-cov-2. Described herein are antibodies or variants thereof that sp...
Invention Antibodies that bind tumor tissue for diagnosis and therapy. Provided herein are antibodies that...
Invention Atrc-101 target expression assay. Disclosed herein are methods and compositions for selecting pat...
Invention Anti-csp antibodies. The present disclosure provides anti-circumsporozoite (CSP) antibodies, comp...
Invention Analysis of nucleic acids associated with single cells using nucleic acid barcode. Provided here...
Invention Antibodies to sars-cov-2. Described herein are antibodies or variants thereof that specifically ...
Invention Antibodies to sars-cov-2. Described herein are antibodies or variants thereof that specifically b...
Invention Epha2 antibodies. Provided herein are EphA2 antibodies. These EphA2 antibodies bind preferentiall...
Invention Use of nanoexpression to interrogate antibody repertoires. Disclosed herein are methods and comp...
2021 Invention Antibody scaffold structure. Provided herein are antibodies comprising a scaffold region and meth...
Invention Combinatorial sets of nucleic acid barcodes for analysis of nucleic acids associated with single ...
G/S Diagnostic preparations for scientific research; biological tissue cultures for scientific resea...
Invention High throughput linking of multiple transcripts. Provided are high throughput methods for physic...
Invention High throughput linking of multiple transcripts. Provided are high throughput methods for physica...
2020 Invention Anti-hiv antibodies. Provided herein are anti-HIV antibodies, compositions comprising such antib...
Invention Anti-csp antibody variants. Provided herein are anti-circumsporozoite (CSP) antibodies, composit...
Invention Anti-csp antibody variants. Provided herein are anti-circumsporozoite (CSP) antibodies, compositi...
Invention Antibodies that bind tumor tissue for diagnosis and therapy. Provided herein are antibodies that ...
Invention Antibodies that bind tumor tissue, and their diagnostic and therapeutic uses. Provided herein are...
2019 G/S Biological assays consisting primarily of monoclonal antibodies, pre-made buffer concentrates, an...
G/S Biologics for medical use, namely, biological preparation for the treatment of cancer
Invention Anti-hiv antibodies. Provided herein are anti-HIV antibodies, compositions comprising such antibo...
Invention Nucleic acids encoding anti-hiv antibodies. This application provides oligonucleotide composition...
2018 Invention Anti-malarial antibodies that bind circumsporozoite protein. P. falciparum by insect vector trans...
Invention Anti-malarial antibodies that bind circumsporozoite protein. Antibodies that bind to the circumsp...
2017 Invention Use of nanoexpression to interrogate antibody repertoires. Disclosed herein are methods and compo...
G/S Antibodies for clinical use Biologics for medical use, namely, biological preparation for the tre...
2016 G/S Research, design and development of diagnostics for predicting or monitoring the response of pati...
2014 Invention Analysis of nucleic acids associated with single cells using nucleic acid barcodes. Provided here...
Invention Use of nanoexpression to interrogate antigen repertoires. Disclosed herein are methods and compo...
2013 G/S Diagnostic preparations and diagnostic kits comprised of buffers and reagents for clinical, medic...
2012 G/S Molecular biology research for diagnostic preparations, biologics, combinations of diagnostic pre...
Invention Dna barcodes for multiplexed sequencing. The present disclosure provides methods for optimizing b...
2011 G/S Research, design and development of diagnostics for predicting the response of patients to therap...
G/S Diagnostics and diagnostic kits consisting primarily of buffers and reagents, for predicting the ...